Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-24-009379

Options or other derivatives

  • Chief Financial Officer acquired 650,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Howe Jill Ann · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-03-07 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +650,000 650,000 D
Loading xslF345X05/ownership.xml…